carbon monoxide has been researched along with Local Neoplasm Recurrence in 2 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we evaluated the effect of smoking cessation on definitive radiation therapy for early stage glottic carcinoma by monitoring expiratory carbon monoxide (CO)." | 8.02 | Monitoring expiratory carbon monoxide to study the effect of complete smoking cessation on definitive radiation therapy for early stage glottic carcinoma. ( Hirata, T; Inohara, H; Isohashi, F; Miyata, Y; Ogawa, K; Seo, Y; Shimamoto, S; Tamari, K; Tatekawa, S; Uno, A; Yamamoto, Y; Yoshino, Y, 2021) |
| " Here, we evaluated the effect of smoking cessation on definitive radiation therapy for early stage glottic carcinoma by monitoring expiratory carbon monoxide (CO)." | 4.02 | Monitoring expiratory carbon monoxide to study the effect of complete smoking cessation on definitive radiation therapy for early stage glottic carcinoma. ( Hirata, T; Inohara, H; Isohashi, F; Miyata, Y; Ogawa, K; Seo, Y; Shimamoto, S; Tamari, K; Tatekawa, S; Uno, A; Yamamoto, Y; Yoshino, Y, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tatekawa, S | 1 |
| Shimamoto, S | 1 |
| Miyata, Y | 1 |
| Yoshino, Y | 1 |
| Hirata, T | 1 |
| Tamari, K | 1 |
| Seo, Y | 1 |
| Isohashi, F | 1 |
| Yamamoto, Y | 1 |
| Uno, A | 1 |
| Inohara, H | 1 |
| Ogawa, K | 1 |
| Webster, M | 1 |
| Cairncross, G | 1 |
| Gertler, S | 1 |
| Perry, J | 1 |
| Wainman, N | 1 |
| Eisenhauer, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Study of SarCNU (NSC 364432) in Patients With Malignant Glioma[NCT00036660] | Phase 2 | 10 participants (Actual) | Interventional | 2002-01-10 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for carbon monoxide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Phase II trial of SarCNU in malignant glioma: unexpected pulmonary toxicity with a novel nitrosourea: a phase II trial of the national cancer institute of canada clinical trials group.
Topics: Academies and Institutes; Adult; Aged; Antineoplastic Agents; Astrocytoma; Canada; Carbon Monoxide; | 2005 |
1 other study available for carbon monoxide and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Monitoring expiratory carbon monoxide to study the effect of complete smoking cessation on definitive radiation therapy for early stage glottic carcinoma.
Topics: Carbon Monoxide; Carcinoma, Squamous Cell; Glottis; Humans; Laryngeal Neoplasms; Neoplasm Recurrence | 2021 |